Evaluating of effect of infiltration of bupivacaine local anesthetic in post-operative pain relief in patients undergoing Laparoscopic Gallbladder Surgery

Evaluating of effect of infiltration of bupivacaine local anesthetic to port site in post-operative pain relief in laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017020632419N1

Enrollment

Registered

2017-03-13

Start date

2017-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain. Complication of surgical and medical care, unspecified

Interventions

Intervention 1: In case groups

at the end of surgery before closing the surgical incision

10 cc Bupivacaine 0.25% into two trocar sites( In each place 5 cc) were infiltrated. Intervention 2: In control group

10 cc normal saline into two trocar sites (In each place 5 cc) were infiltrated.

Prevention

Placebo

In case groups

10 cc Bupivacaine 0.25% into two trocar sites( In each place 5 cc) were infiltrated.

In control group

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients 20 to 70 years old; the category of America Society of Anesthesiology (ASA) are class 1 and 2; undergoing elective surgery laparoscopic cholecystectomy; consent to participate up to the end study. Exclusion criteria: patients with history of Diabetes; former bile ducts surgeries; sensitivity to local anesthesia drugs; addiction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post operative pain. Timepoint: At 1, 2, 4, 12 and 24 hours after surgery. Method of measurement: According to VAS pain score systems.;Nausea and vomiting. Timepoint: Every 1 hour during first 4 hours after transferring to the ward. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehdi Hajizade

Qazvin University of Medical Sciences

dr.mehdi.hajizadeh@gmail.com+98 28 3376 0620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026